Quick Order

Home>IL1B
Text Size:AAA

IL1B/IL-1B/IL-1 beta  Protein, Antibody, ELISA Kit, cDNA Clone

Description: Active  
Expression host: E. coli  
10139-HNAE-500
10139-HNAE-5
10139-HNAE-20
10139-HNAE-100
10139-HNAE-1
500 µg 
5 µg 
20 µg 
100 µg 
1 mg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: E. coli  
10139-H07E-50
10139-H07E-20
50 µg 
20 µg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: E. coli  
50101-MNAE-500
50101-MNAE-5
50101-MNAE-20
50101-MNAE-100
50101-MNAE-1
500 µg 
5 µg 
20 µg 
100 µg 
1 mg 
Add to Cart
  • Slide 1
Expression host: E. coli  
80023-R07E-50
80023-R07E-20
50 µg 
20 µg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: E. coli  
80023-RNAE-5
80023-RNAE-20
80023-RNAE-100
5 µg 
20 µg 
100 µg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: E. coli  
90010-CNAE-500
90010-CNAE-5
90010-CNAE-20
90010-CNAE-100
90010-CNAE-1
500 µg 
5 µg 
20 µg 
100 µg 
1 mg 
Add to Cart
  • Slide 1
Description: Active  
Expression host: E. coli  
70018-DNAE-5
70018-DNAE-20
70018-DNAE-100
5 µg 
20 µg 
100 µg 
Add to Cart
  • Slide 1
Expression host: E. coli  
65004-TNAE-5
65004-TNAE-20
65004-TNAE-100
5 µg 
20 µg 
100 µg 
Add to Cart
  • Slide 1
Expression host: E. coli  
62003-WNAE-5
62003-WNAE-20
62003-WNAE-10
5 µg 
20 µg 
10 µg 
Add to Cart
  • Slide 1
Expression host: E. coli  
67002-UNAE-5
67002-UNAE-20
67002-UNAE-10
5 µg 
20 µg 
10 µg 
Add to Cart
  • Slide 1

IL1B/IL-1B/IL-1 beta Related Area

IL1B/IL-1B/IL-1 beta Related Pathways

    IL1B/IL-1B/IL-1 beta Related Protein, Antibody, cDNA Gene, and ELISA Kits

    Featured Reagent Products

    IL1B/IL-1B/IL-1 beta Summary & Protein Information

    IL1B/IL-1B/IL-1 beta Background

    Subunit structure: Monomer. Interacts with MEFV. {ECO:0000269|PubMed:17431422, ECO:0000269|PubMed:20802483}.
    Domain: The similarity among the IL-1 precursors suggests that the amino ends of these proteins serve some as yet undefined function.
    Subcellular location: Secreted. Note=The lack of a specific hydrophobic segment in the precursor sequence suggests that IL-1 is released by damaged cells or is secreted by a mechanism differing from that used for other secretory proteins.
    Sequence similarity: Belongs to the IL-1 family. {ECO:0000305}.
    General information above from UniProt

    Interleukin-1 beta (IL1 beta or IL1B) also known as catabolin, is a member of the interleukin 1 cytokine family. IL1 is a pleiotropic cytokine. It is involved in the inflammatory response, cell growth, and tissue repair in the cortex. The IL1 superfamily consists of three members, IL1A (IL1 alpha), IL1B (IL1 beta), and IL1 receptor antagonist (IL1Ra). In clinical, it has been reported that Interleukin (IL)-1 may influence Th1 / Th2 immune responsiveness and has been implicated in the establishment of successful pregnancy. Proinflammatory interleukin (IL)-1 gene polymorphisms associated with high levels of IL-1beta activity increase the risk for hypochlorhydria and distal gastric carcinoma. IL1B polymorphisms may be involved in susceptibility to SSc. Moreover, the IL2-384-G allele may be a marker for the limited phenotype of systemic sclerosis (SSc).

    IL1B/IL-1B/IL-1 beta Alternative Name

    IL-1,IL1F2,IL1-BETA, [homo-sapiens]
    IL-1,IL-1 beta,IL1B,IL1-BETA,IL1F2, [human]
    Il-1b,IL-1beta, [Mouse]
    Il-1b,IL-1beta, [mus-musculus]

    IL1B/IL-1B/IL-1 beta Related Studies

  • Kim SH, et al. (2008) Association of -31TC and -511 CT polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Mol Vis. 14:2109-16.
  • Wang ZC, et al. (2002) T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Genes Immun. 3(1): 38-42.
  • Mattuzzi S, et al. (2007) Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol. 34(5): 997-1004.
  • Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"